PSMD1 inhibitors belong to a chemical class designed to modulate the activity of the PSMD1 protein, also known as 26S proteasome non-ATPase regulatory subunit 1. PSMD1 is a crucial component of the 26S proteasome, which is a large protein complex responsible for the degradation of ubiquitinated proteins within the cell. The 26S proteasome plays a pivotal role in maintaining protein homeostasis, regulating cellular processes, and controlling the turnover of specific proteins.
Inhibitors targeting PSMD1 aim to interfere with its role in the assembly and function of the 26S proteasome complex. By modulating PSMD1, these inhibitors impact the ubiquitin-proteasome system's ability to degrade specific target proteins, thus influencing various cellular pathways and processes that rely on protein turnover. Developing PSMD1 inhibitors involves designing compounds that interact with the protein's active site or specific domains, disrupting its role in proteasome assembly and function. By inhibiting PSMD1, researchers aim to gain insights into the complex regulation of protein degradation and explore the broader implications of targeting this protein for cellular processes and physiological responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CDDO Methyl Ester | 218600-53-4 | sc-504720 | 10 mg | $220.00 | ||
CDDO Methyl Ester inhibits KLHL9 by blocking its interaction with substrate proteins, thereby preventing the formation of functional KLHL9-containing E3 ubiquitin ligase complexes involved in protein ubiquitination and degradation pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Approved for the treatment of multiple myeloma and mantle cell lymphoma. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane inhibits KLHL9 activity by disrupting its interaction with Cul3, a crucial component of the Cul3-KLHL9 E3 ubiquitin ligase complex, leading to impaired ubiquitination and degradation of substrate proteins targeted by KLHL9. | ||||||
Dimethyl fumarate | 624-49-7 | sc-239774 | 25 g | $28.00 | 6 | |
Dimethyl fumarate inhibits KLHL9 function by interfering with its ability to recruit substrate proteins for ubiquitination, thereby disrupting the proteasomal degradation pathway regulated by KLHL9-mediated ubiquitination. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz inhibits KLHL9 activity by modulating its conformation or stability, leading to impaired assembly of functional KLHL9-containing E3 ubiquitin ligase complexes and subsequent inhibition of substrate protein ubiquitination. | ||||||